Profound Medical Corp. (PROF) Form 8-K — Nov 3, 2026
Profound Medical's U.S. subsidiary entered a supply and distribution agreement with Cook Medical's iMRI Division, appointing Cook as a non-exclusive U.S. distributor of the TULSA-PRO system within Cook's iMRI Suite and Copernicus program. The deal creates a new capital equipment sales channel alongside Profound's existing Siemens Healthineers partnership.
Key figures
- Cure period days
- 30
- Initial term years
- 5
- Termination notice days
- 180
- Regulatory approval deadline
- April 30, 2027
AI analysis
Red flags4 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.